Effectiveness of a pharmacy-led personalised intervention program aimed at improving adherence to oral diabetes and/or hypertension medication in people with type 2 diabetes

A pharmacy-led personalised adherence program showed no significant improvement in medication adherence over six months versus usual care in 68 non-adherent people with type 2 diabetes.

• Why it matters: Non-adherence to oral diabetes and/or hypertension medicines remains a clinical problem, and it is unclear whether a pharmacy-personalised approach improves adherence beyond standard support.
• What they did: In a parallel-group randomized trial in community pharmacies in the Netherlands and United Kingdom, non-adherent adults with type 2 diabetes received the personalised program or usual care plus an informative diabetes website; adherence was assessed by telephone pill count.
• The result: Medication adherence had no significant intervention effect (B -0.014, 95% CI -0.17 to 0.14), with no significant differences for self-reported adherence, systolic blood pressure, or HbA1c, so the program is not recommended for daily practice.

AI summary of the abstract · may contain errors · not medical advice · read the paper.